Veracyte | VCYT - Interest Expense On Debt


Veracyte reported $2K in Interest Expense on Debt for its fiscal quarter ending in December of 2023.





Interest Expense On Debt Change Date
Agenus USD 14.67M 1.35M Mar/2026
Agilent USD 25M 0 Mar/2026
Anika Therapeutics 183.47M 4.09M Jun/2026
Arrowhead Research USD 24.56M 716K Jun/2026
Bruker USD 17.8M 9.7M Jun/2026
Heron Therapeutics USD 600K 100K Dec/2024
Illumina USD 24M 2M Mar/2026
Intrexon USD 2K 5K Jun/2024
Karyopharm Therapeutics USD 12.55M 66K Mar/2026
Laboratory Of America USD 61.1M 6M Jun/2026
Ligand Pharmaceuticals USD 1.78M 875K Dec/2025
Myriad Genetics USD 4.4M 600K Dec/2025
Rigel Pharmaceuticals USD 2.06M 31K Sep/2024
Roche Holding CHF 304M 7.5M Jun/2025
Sangamo BioSciences 97.56M 11.39M Jun/2025
Siemens EUR 371M 64M Jun/2026
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Thermo Fisher Scientific USD 354M 11M Mar/2026
Veracyte USD 2K 1000 Dec/2023
Waters USD 55M 13M Jun/2026